Organization: Health Canada
Year: 2022
Month: July
Request Number: A-2021-002092
Request Summary: The Screening acceptance letter(s) sent by Health Canada to any and all generic drug manufacturer(s) regarding any and all Abbreviated New Drug Submissions for the following medicinal ingredients or combinations of medicinal ingredients: Amphotericin B, Buffer solution-melphalan hydrochloride, Lidocaine-prilocaine, Rocuronium bromide, Cabazitaxel, fesoterodine fumarate which were been added to the list of Generic Submissions Under Review dated March 15, 2022.
Disposition: Disclosed in part
Number of pages: 6